Profesora Silvia de Sanjosé: En mi país se está haciendo la propuesta de cribar con pruebas moleculares para el VPH y dejar los estudios citológicos para mujeres que resulten positivas para estas pruebas. Mi pregunta es si existe la posibilidad de que pacientes con cáncer de cuello uterino pudieran resultar negativas para genotipificación viral, teniendo presente que en pacientes con lesiones de avanzadas puede disminuir la carga viral.

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.